Comparison of the Efficacy Among Nilotinib, Dasatinib, Flumatinib and Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients: A Real-World Multi-Center Retrospective Study

作者：Xiaoshuai Zhang, Na Xu, Yunfan Yang, Hai Lin, Bingcheng Liu, Xin Du, Xiaoli Liu, Rong Liang, Chunyan Chen, Jian Huang, Huanling Zhu, Ling Pan, Xiaodong Wang, Guohui Li, Zhuogang Liu, Yanqing Zhang, Yanqing Zhang, Liu Zd, Jianda Hu, Fei Li, Feng Li, Wei Yang, Li Meng, Yanqiu Han, Li'e Lin, Zhenyu Zhao, Chuanqing Tu, Caifeng Zheng, Yanliang Bai, Zeping Zhou, Suning Chen, Qiu Huiying, Lijie Yang, Hui Sun, HD Sun, Li Zhou, Liu Zd, Danyu Wang, Guo J, Liping Pang, Qingshu Zeng, Xiaohui Suo, Yuanjun Zheng, Yanli Zhang, Yu Zhang, Yanli Zhang, Weiming Li, Qian Jiang · 发表于：Clinical Lymphoma Myeloma & Leukemia · 年份：2024 · DOI：10.1016/j.clml.2024.02.008 · 被引用次数：9 · 研究领域：Chronic Myeloid Leukemia Treatments、Myeloproliferative Neoplasms: Diagnosis and Treatment、Eosinophilic Disorders and Syndromes